ABAD, Etna, Yoelsis GARCIA-MAYEA, Cristina MIR, David SEBASTIAN, Antonio ZORZANO, David POTĚŠIL, Zbyněk ZDRÁHAL, Alex LYAKHOVICH and Matilde LLEONART. Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer. Molecular and Cellurar Proteomic. American Society for Biochemistry and Molecular Biology, 2019, vol. 18, No 2, p. 231-244. ISSN 1535-9476. Available from: https://dx.doi.org/10.1074/mcp.RA118.001102.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer
Authors ABAD, Etna (724 Spain), Yoelsis GARCIA-MAYEA (724 Spain), Cristina MIR (724 Spain), David SEBASTIAN (724 Spain), Antonio ZORZANO (724 Spain), David POTĚŠIL (203 Czech Republic, belonging to the institution), Zbyněk ZDRÁHAL (203 Czech Republic, guarantor, belonging to the institution), Alex LYAKHOVICH (724 Spain) and Matilde LLEONART (724 Spain).
Edition Molecular and Cellurar Proteomic, American Society for Biochemistry and Molecular Biology, 2019, 1535-9476.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.870
RIV identification code RIV/00216224:14740/19:00107512
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1074/mcp.RA118.001102
UT WoS 000457454000005
Keywords in English STEM-CELLS; DYSFUNCTION; AUTOPHAGY; HYDROXYCHLOROQUINE; TOXICITY; TARGET; GROWTH; ACID
Tags CF PROT, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 31/3/2020 21:26.
Abstract
Cancer cells are known to reprogram their metabolism to adapt to adverse conditions dictated by tumor growth and microenvironment. A subtype of cancer cells with stem-like properties, known as cancer stem cells (CSC), is thought to be responsible for tumor recurrence. In this study, we demonstrated that CSC and chemoresistant cells derived from triple negative breast cancer cells display an enrichment of up-and downregulated proteins from metabolic pathways that suggests their dependence on mitochondria for survival. Here, we selected antibiotics, in particular - linezolid, inhibiting translation of mitoribosomes and inducing mitochondrial dysfunction. We provided the first in vivo evidence demonstrating that linezolid suppressed tumor growth rate, accompanied by increased autophagy. In addition, our results revealed that bactericidal antibiotics used in combination with autophagy blocker decrease tumor growth. This study puts mitochondria in a spotlight for cancer therapy and places antibiotics as effective agents for eliminating CSC and resistant cells.
Links
GBP206/12/G151, research and development projectName: Centrum nových přístupů k bioanalýze a molekulární diagnostice
LM2015043, research and development projectName: Česká infrastruktura pro integrativní strukturní biologii (Acronym: CIISB)
Investor: Ministry of Education, Youth and Sports of the CR
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 22/5/2024 12:04